Effects of autologous serum eye drops on corneal wound healing after superficial keratectomy in rabbits

Cornea

Volumn 25, Issue 10, 2006, Pages 1178-1181

  Akyol Salman, Ilknur ^a,b  

^a ATATURK UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Artificial tear; Autologous serum; Corneal ulcer; Corneal wound healing; Superficial keratectomy

Indexed keywords

ARTIFICIAL TEAR; AUTOLOGOUS SERUM EYE DROPS; EYE DROPS; OXYBUPROCAINE; SODIUM CHLORIDE; TEARS NATURALE FREE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD AUTOTRANSFUSION; CONTROLLED STUDY; CORNEA INJURY; CORNEA NEOVASCULARIZATION; CORNEA ULCER; DRUG EFFECT; FLUORESCENCE; KERATECTOMY; MALE; NONHUMAN; PRIORITY JOURNAL; SERUM; SLIT LAMP; STAINING; STATISTICAL SIGNIFICANCE; VASCULARIZATION; WOUND HEALING;

ADMINISTRATION, TOPICAL; ANIMALS; CORNEA; CORNEAL ULCER; DISEASE MODELS, ANIMAL; FOLLOW-UP STUDIES; MALE; OPHTHALMIC SOLUTIONS; RABBITS; SERUM; WOUND HEALING;

EID: 33845802499     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000208817.40237.8c     Document Type: Article

References (28)

1. Cassell OC, Hofer SO, Morrison WA, et al. Vascularization of tissue-engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states. Br J Plast Surg. 2002;55:603-610.
2. Bray RC, Leonard CA, Salo PT. Correlation of healing capacity with vascular response in the anterior cruciate and medial collateral ligaments of the rabbit. J Orthop Res. 2003;21:1118-1123.
3. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931-10934.
4. Irvin TT, ed. Wound Healing: Principles and Practice. London: Chapman Hall; 1981:12-36.
5. Nishida T. Cornea. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea: Fundamentals, Diagnosis and Management. Philadelphia, PA: Elsevier Mosby; 2005:3-26.
6. Pepose JS, Ubels JL. The cornea. In: Hart WM, ed. Adler's Physiology of the Eye. St. Louis, MO: Mosby; 1992:29-63.
7. Kaufman HE, Baron BA, McDonald MB, et al, eds. Companion Handbook to the Cornea. Boston, MA: Butterworth-Heinemann; 2000:3-12.
8. Dua HS, Gomes JAP, Singh A. Corneal epithelial wound healing. Br J Ophthalmol. 1994;78:401-408.
9. Tsubota K, Goto E, Shimmura S, et al. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology. 1999;106:1984-1989.
10. Zieske JD, Gipson IK. Agents that affect corneal wound healing: modulation of structure and function. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology: Basic Sciences. Philadelphia, PA: W.B. Saunders; 1994:1093-1099.
11. Zieske JD, Gipson IK. Protein synthesis during corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 1986;27:1-7.
12. Tuli S, Goldstein M, Schultz GS. Modulation of corneal wound healing. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea: Fundamentals, Diagnosis and Management. Philadelphia, PA: Elsevier Mosby; 2005: 133-150.
13. Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol. 1999;83:390-395.
14. Geerling G, MacLennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004;88:1467-1474.
15. Hori Y, Spurr-Michaud S, Russo CL, et al. Differential regulation of membrane-associated mucins in the human ocular surface epithelium. Invest Ophthalmol Vis Sci. 2004;45:114-122.
16. Trinkaus-Randall V, Gipson IK. Role of calcium and calmodulin in hemidesmosome formation in vitro. J Cell Biol. 1984;98:1565-1571.
17. Fox R, Chan R, Michelson J, et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum. 1984;27:459-461.
18. Tsubota K, Satake Y, Shimazaki J. Treatment of severe dry eye. Lancet. 1996;348:123.
19. Tsubota K, Satake Y, Ohyama M, et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol. 1996;122:38-52.
20. Poon AC, Geerling G, Dart JK, et al. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol. 2001;85:1188-1197.
21. Tananuvat N, Daniell M, Sullivan LJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea. 2001;20:802-806.
22. Goto E, Shimmura S, Shimazaki J, et al. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea. 2001;20:807-810.
23. Ferreira de Souza R, Kruse FE, Seitz B. Autologous serum for otherwise therapy resistant corneal epithelial defects - Prospective report on the first 70 eyes. Klin Monatsbl Augenheilkd. 2001;218:720-726.
24. Ogawa Y, Okamoto S, Mori T, et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant. 2003;31:579-583.
25. Garcia Jimenez V, Veiga Villaverde B, Baamonde Arbaiza B, et al. The elaboration, use and evaluation of eye-drops with autologous serum in corneal lesions. Farm Hosp. 2003;27:21-25.
26. Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology. 2004;111:1115-1120.
27. Djalilian AR, Hamrah P, Pflugfelder SC. Dry eye. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea: Fundamentals, Diagnosis and Management. Philadelphia, PA: Elsevier Mosby; 2005:521-540.
28. Geerling G, Daniels JT, Dart JK, et al. Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2001;42:948-956.